ProMIS Neurosciences Inc. (PMN) Stock Forecast & Price Target
ProMIS Neurosciences Inc. · NASDAQ
$12.43-0.17 (-1.37%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering ProMIS Neurosciences Inc, 5 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. The target range is very wide, $18.00 to $100.00 (about 5.6x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $42.50 sits 242% above the current $12.43. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 3 to 5 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-1.95 next quarter toward $-5.60 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Strong Buy
Strong Buy00%
Buy5100%
Hold00%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to ProMIS Neurosciences Inc.
As of Sep, 5 of 5 firms rate PMN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
PMN EPS & revenue forecast
EPS · NEXT QUARTER
$-1.95
Range $-2.05 – $-1.86 · 2 analysts
Next period, 2 analysts expect ProMIS Neurosciences Inc. to earn $-1.95 a share (range $-2.05 – $-1.86), versus — a year earlier. Full-year consensus is $-7.36, growing to $-5.60 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 2 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $0 next year.
Top analysts covering ProMIS Neurosciences Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PMN.
#1
Yatin Suneja
Guggenheim · Rank #21
Buy
$100.00+704.7% to target
Overall win rate
53%
+ Follow
#2
Keay Nakae
Chardan Capital · Rank #89
Buy
$33.00+165.6% to target
Overall win rate
43%
+ Follow
#3
PS
Pete Stavropoulos
Cantor Fitzgerald · Rank #233
Buy
No targeton PMN
Overall win rate
36%
+ Follow
#4
Raghuram Selvaraju
HC Wainwright & Co. · Rank #312
Buy
$18.00+44.8% to target
Overall win rate
36%
+ Follow
#5
Jason McCarthy
Maxim Group · Rank #428
Buy
$35.00+181.6% to target
Overall win rate
32%
+ Follow
PMN stock forecast FAQ
What is PMN's average 12-month price target?+
The 4 analysts with a live target average $42.50 for ProMIS Neurosciences Inc. over the next 12 months, ranging from a $100.00 high to a $18.00 low.
Is PMN stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 5 analyst ratings, 5 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for PMN?+
The Street-high target is $100.00 (Guggenheim), and the Street-low is $18.00 (HC Wainwright & Co.). The average of all 4 active targets is $42.50.
How many Wall Street analysts cover PMN?+
5 analysts have an active rating on ProMIS Neurosciences Inc., and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering PMN?+
Among analysts who currently cover PMN, Yatin Suneja of Guggenheim has the strongest overall Quantellect track record (Rank #21). Their current call is Buy with a $100.00 target.
What is ProMIS Neurosciences Inc.'s projected EPS for next quarter?+
The consensus estimate is $-1.95 per share (range $-2.05 – $-1.86) across 2 analysts. Full-year EPS is projected at $-7.36, rising to $-5.60 the following year.
How much revenue is ProMIS Neurosciences Inc. expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading PMN lately?+
As of Sep, 5 of 5 firms rate PMN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PMN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
